Cargo agrees to Concentra buyout after trial setback, layoffs
BioPharma Drive: Drug Pricing
JULY 8, 2025
The cell therapy developer, which raised nearly $500 million in 2023 on the promise of its CAR-T work, has floundered since a safety setback forced it to scrap its lead candidate.
Let's personalize your content